Position
General Counsel
Company
Exelixis
AlamedaBiotechnologyHealth CareTherapeuticsresearchDescription
On November 4, 2025, Exelixis, Inc announced the promotion of Brenda Hefti, JD, PhD, to the position of General Counsel, effective November 7, 2025. This appointment follows the resignation of Jeffrey Hessekiel, JD, who is set to leave his role as General Counsel at the same time. Dr Hefti has been with the company since 2013 and previously served as Senior Vice President, Intellectual Property & Licensing.
Quick answer
Exelixis Appoints Brenda Hefti as General Counsel (November 7, 2025). Exelixis is based in Alameda, California, United States.
- Who is the new General Counsel at Exelixis?
- Exelixis named Brenda Hefti General Counsel, announced November 7, 2025.
- What did Exelixis announce on November 7, 2025?
- On November 4, 2025, Exelixis, Inc announced the promotion of Brenda Hefti, JD, PhD, to the position of General Counsel, effective November 7, 2025. This appointment follows the resignation of Jeffrey Hessekiel, JD, who is set to leave his role as General Counsel at the same time.
- What does Exelixis do?
- Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care.
- Where is Exelixis based?
- Exelixis is based in Alameda, California, United States.
- Which similar companies made leadership changes around the same time?
- Syndeio Biosciences (November 4, 2025), Celldex (November 11, 2025), Draig Therapeutics (November 3, 2025) and Aktis Oncology (November 5, 2025) also announced leadership changes within 45 days of Exelixis.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and research
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Syndeio Biosciences Appoints Aaron Koenig, M.D., as Chief Medical Officer (November 4, 2025)
- Celldex Therapeutics Appoints Teri Lawver as Chief Commercial Officer (November 11, 2025)
- Draig Therapeutics Appoints Ivana Magovčević-Liebisch as CEO (November 3, 2025)
- Aktis Oncology Appoints Kyle Kuvalanka as Chief Financial Officer (November 5, 2025)
- QurAlis Appoints Manoj Malhotra, M.D., as Chief Medical Officer (November 10, 2025)
- Edgewise Therapeutics Appoints Michael Nofi as Chief Financial Officer (November 10, 2025)
Who to call at Exelixis, and when
A new leader at Exelixis brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Exelixis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Exelixis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Exelixis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Exelixis changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Exelixis changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.